Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Strategic siRNA screening approaches to target cancer at the Cancer Research UK Beatson Institute.

Combinatorial chemistry & high throughput screening - 1 May 2014

Shanks Emma J

Abstract excerpt

The RNAi Screening Facility at the Cancer Research UK Beatson Institute combines siRNA genome-wide screening with drug screening coupled with High Content Imaging and fluorescence-based phenotypic assays to target multiple types of cancer. Here, we describe the infrastructure of the Facility and the approaches we utilise. We also share our experiences in running such a facility and developing and executing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Data Interpretation, Statistical
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Screening Assays, Antitumor

Share to High-Throughput Screening Assays

Share to Neoplasms

Share to RNA Interference

Share to United Kingdom

Source

Identifiers

PMID: 24661213
DOI: 10.2174/1386207317666140323133249

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Strategic siRNA screening approaches to target cancer at the Cancer Research UK Beatson Institute.PMID 24661213Read ↗

Increasing the Content of High-Content Screening: An Overview.Semantic proximity Read ↗

High-content assays in oncology drug discovery: opportunities and challenges.Semantic proximity Read ↗

Fluorescence-Based High-Throughput and Targeted Image Acquisition and Analysis for Phenotypic Screening.Semantic proximity Read ↗

Multimodal imaging reveals a lysosomal drug reservoir that drives heterogeneous distribution of PARP inhibitorsSemantic proximity Read ↗

Image-based high-content screening in drug discovery.Semantic proximity Read ↗

A Scalable 3D High-Content Imaging Protocol for Measuring a Drug Induced DNA Damage Response Using Immunofluorescent Sub-nuclear γH2AX Spots in Patient Derived Ovarian Cancer OrganoidsSemantic proximity Read ↗

High-content phenotypic profiling of drug response signatures across distinct cancer cells.Semantic proximity Read ↗

Multiparametric Analysis of Screening Data: Growing Beyond the Single Dimension to Infinity and Beyond.Semantic proximity Read ↗

A Multivariate Computational Method to Analyze High-Content RNAi Screening Data.Semantic proximity Read ↗

Prioritizing hits from phenotypic high-content screens.Semantic proximity Read ↗

Androgen receptor functional analyses by high throughput imaging: determination of ligand, cell cycle, and mutation-specific effects.Semantic proximity Read ↗

Label-free cell phenotypic profiling decodes the composition and signaling of an endogenous ATP-sensitive potassium channel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.